New Report Available: Analgesics in Germany
Despite the high level of saturation and maturity in analgesics in Germany, the category achieved current value growth of 1% in 2013. Much of this growth was a result of the self-medication trend, which was heavily driven by large-scale advertising campaigns from the major manufacturers. For example, Boehringer Ingelheim invested heavily in television advertising in order to stimulate demand for its Thomapyrin brand. Acetaminophen, aspirin and caffeine are all active ingredients in Thomapyrin. Acetaminophen and aspirin both posted a current...
View full press release